Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 190Breast 110Thoracic 41Genitourinary 37Gynecologic 33Head & Neck 27Sarcoma 26CNS 20Tumor-Agnostic 8Lymphoid 7Plasma cell 6Other solid neoplasm 4Dermatologic 3Other hematologic neoplasm 2Endocrine 1Classical hematology 1

Conditions

Gastrointestinal Neoplasms 1Carcinoma, Neuroendocrine 1

Interventions

Everolimus 61lutetium Lu 177 dotatate 53Magnetic Resonance Spectroscopy 39pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 25lanreotide 24gallium Ga 68 dotatate 24cabozantinib 22pasireotide 21lenvatinib 203-Iodobenzylguanidine 20Etoposide 19Sunitinib 18Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18surufatinib 16Bevacizumab 16trametinib 15dabrafenib 15Sorafenib 14Doxorubicin 14Ipilimumab 13Thyrotropin Alfa 12Surgical Procedures, Operative 12Injections 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoadjuvant Therapy × Endocrine × Clear all
NCT04268121 2025-07-23

NEONEC

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 2 Recruiting
78 enrolled
EndocrineGastrointestinal

Gastrointestinal Neoplasms, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡